U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C44H88NO8P
Molecular Weight 790.1452
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DISTEAROYLPHOSPHATIDYLCHOLINE, DL-

SMILES

CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC

InChI

InChIKey=NRJAVPSFFCBXDT-UHFFFAOYSA-N
InChI=1S/C44H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h42H,6-41H2,1-5H3

HIDE SMILES / InChI

Molecular Formula C44H88NO8P
Molecular Weight 790.1452
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

DISTEAROYLPHOSPHATIDYLCHOLINE, DL- (DSPC) is a component of LUMASON® (sulfur hexafluoride lipid-type A microspheres). It is an ultrasound contrast agent indicated for use in the heart echocardiography and in ultrasonography of the liver and the urinary tract. The sulfur hexafluoride lipid microspheres are composed of SF6 gas in the core surrounded by an outer shell monolayer of phospholipids such as DSPC.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
LUMASON

Approved Use

Lumason is an ultrasound contrast agent indicated for use - in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms - in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients - in ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux in pediatric patients

Launch Date

2014
Diagnostic
LUMASON

Approved Use

Lumason is an ultrasound contrast agent indicated for use - in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms - in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients - in ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux in pediatric patients

Launch Date

2014
Diagnostic
LUMASON

Approved Use

Lumason is an ultrasound contrast agent indicated for use - in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms - in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients - in ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux in pediatric patients

Launch Date

2014

Sample Use Guides

Echocardiography: After reconstitution, administer LUMASON® 2 mL as an intravenous injection in adult patients. Ultrasonography of the liver in adults: After reconstitution, administer LUMASON® 2.4 mL as an intravenous injection.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:19:26 GMT 2023
Edited
by admin
on Fri Dec 15 15:19:26 GMT 2023
Record UNII
EAG959U971
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DISTEAROYLPHOSPHATIDYLCHOLINE, DL-
Common Name English
1,2-DISTEAROYLLECITHIN
Common Name English
1,2-DISTEAROYL PHOSPHATIDYLCHOLINE, (±)-
Common Name English
1,2-DISTEAROYL-DL-PHOSPHATIDYLCHOLINE
Common Name English
DSPC DL-
Common Name English
DIOCTADECANOYL PHOSPHATIDYLCHOLINE
Common Name English
Code System Code Type Description
CAS
4539-70-2
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
DAILYMED
EAG959U971
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
PUBCHEM
65146
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
EPA CompTox
DTXSID20963380
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
RXCUI
1426933
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
ALTERNATIVE
DRUG BANK
DB14099
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
RXCUI
1426932
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY RxNorm
FDA UNII
EAG959U971
Created by admin on Fri Dec 15 15:19:26 GMT 2023 , Edited by admin on Fri Dec 15 15:19:26 GMT 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE